Friedenthal Financial Takes $1.02 Million Position in Astera Labs, Inc. $ALAB

Key Points

• Friedenthal Financial has acquired a new position in Astera Labs, Inc. worth approximately $1.02 million, purchasing 11,255 shares in the second quarter.
• Analyst ratings for Astera Labs are positive, with Susquehanna raising its price target to $125 and Needham & Company setting a target of $170, while the average target price is $159.83.
• Insider transactions reveal significant sales of Astera Labs stock, with COO Sanjay Gajendra selling 280,000 shares valued at about $47.6 million, indicating potential insider confidence in future company performance.

Friedenthal Financial acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 11,255 shares of the company's stock, valued at approximately $1,018,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Fred Alger Management LLC increased its position in Astera Labs by 13.0% during the 1st quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company's stock worth $93,087,000 after purchasing an additional 179,638 shares in the last quarter. Hoey Investments Inc. increased its position in Astera Labs by 22.4% during the 2nd quarter. Hoey Investments Inc. now owns 6,121 shares of the company's stock worth $553,000 after purchasing an additional 1,121 shares in the last quarter. Wealth Effects LLC purchased a new stake in Astera Labs during the 2nd quarter worth about $242,000. Realta Investment Advisors purchased a new stake in Astera Labs during the 2nd quarter worth about $214,000. Finally, Sheets Smith Wealth Management purchased a new stake in Astera Labs during the 2nd quarter worth about $481,000. Hedge funds and other institutional investors own 60.47% of the company's stock.

Analyst Ratings Changes

A number of analysts recently commented on ALAB shares. Susquehanna lifted their price objective on Astera Labs from $80.00 to $125.00 and gave the stock a "neutral" rating in a research report on Thursday, August 7th. Needham & Company LLC raised their price target on Astera Labs from $100.00 to $170.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Evercore ISI raised their price target on Astera Labs from $104.00 to $215.00 and gave the stock an "outperform" rating in a research note on Wednesday, August 6th. TD Cowen initiated coverage on Astera Labs in a research note on Wednesday, October 1st. They issued a "hold" rating and a $200.00 price target on the stock. Finally, Deutsche Bank Aktiengesellschaft raised their price target on Astera Labs from $160.00 to $200.00 and gave the stock a "buy" rating in a research note on Tuesday, September 2nd. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $159.83.

Astera Labs Price Performance

NASDAQ ALAB opened at $212.10 on Wednesday. The firm has a market capitalization of $35.26 billion, a P/E ratio of 378.75, a P/E/G ratio of 5.50 and a beta of 1.43. Astera Labs, Inc. has a 1-year low of $47.13 and a 1-year high of $262.90. The business's 50-day simple moving average is $193.63 and its 200-day simple moving average is $121.53.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.33 by $0.11. The business had revenue of $191.93 million for the quarter, compared to analyst estimates of $172.46 million. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The company's revenue was up 149.5% compared to the same quarter last year. During the same period in the previous year, the company posted $0.13 EPS. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. On average, equities research analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Insider Transactions at Astera Labs

In other news, COO Sanjay Gajendra sold 280,000 shares of Astera Labs stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $170.02, for a total value of $47,605,600.00. Following the transaction, the chief operating officer directly owned 5,525,545 shares of the company's stock, valued at $939,453,160.90. The trade was a 4.82% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CFO Michael Truett Tate sold 100,000 shares of Astera Labs stock in a transaction dated Tuesday, August 12th. The shares were sold at an average price of $191.19, for a total value of $19,119,000.00. Following the completion of the transaction, the chief financial officer directly owned 401,496 shares in the company, valued at $76,762,020.24. This represents a 19.94% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 1,320,054 shares of company stock valued at $215,638,632. 12.50% of the stock is currently owned by company insiders.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.